Denise C. Connolly
Department of Molecular Therapeutics
Fox Chase Cancer Center
United States of America
Biography
Denise C. ConnollyEducational Background: PhD, Microbiology, Miami University, 1989. MS, Microbiology, Miami University, 1986. BA, Biology, Postdam College, 1984. Memberships American Association for Cancer Research. Honors & Awards: Sandy Rollman Ovarian Cancer Foundation Trailblazer Award. Society of Gynecologic Oncologists Basic Science Award. NIH Tumor Biology Trainee.
Research Interest
Mechanisms of ovarian cancer dissemination. Targeted therapeutic strategies for treatment of ovarian cancer. Development of mouse models of ovarian cancer. Small animal imaging technologies.
Publications
-
Do, T. V., Xiao, F., Bickel, L. E., Klein-Szanto, A. J., Pathak, H. B., Hua, X., ... & Litwin, S. (2014). Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion. Oncogene, 33(5), 539-549.
-
Liu, H., Xiao, F., Serebriiskii, I. G., O'Brien, S. W., Maglaty, M. A., Astsaturov, I., ... & Connolly, D. C. (2013). Network analysis identifies an HSP90-central hub susceptible in ovarian cancer. Clinical Cancer Research, 19(18), 5053-5067.
-
Gritsina, G., Xiao, F., O'Brien, S. W., Gabbasov, R., Maglaty, M. A., Xu, R. H., ... & Balachandran, S. (2015). Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth. Molecular cancer therapeutics, 14(4), 1035-1047.
